The racemate and the enantiomers of cytosporone E [3-heptyl-4,5,6-trihydroxyphthalide (1)], a metabolite of the endophytic fungus, CR200 (Cytospora sp.), were synthesized. The key steps were (i) Sharpless asymmetric dihydroxylation of an alkene (8) and (ii) HPLC separation of the enantiomers of tert-butyldimethylsilyl ether (12) on a chiral stationary phase. The racemate and enantiomers of cytosporone E showed only weak antimicrobial activity with no diŠerence among them.
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In 2000, Clardy and his co-workers isolated cytosporones A-E as new octaketide metabolites of the endophytic fungus, CR200 (Cytospora sp.). 1) Two of them, cytosporone D and E (1), were reported to show strong antimicrobial activity, while the others were biologically inactive. 1) Their structures were clariˆed mainly by an NMR analysis. In the case of cytosporone C (see Scheme 1), its structure was resolved by an X-ray crystallographic analysis. According to Clardy et al., the space group in which it crystallized required cytosporone C to be isolated as a racemic mixture. 1) Although the speciˆc rotation values of cytosporones were not reported, it could be speculated that cytosporones in general might have been isolated as racemates. This speculation aroused our curiosity to scrutinize whether there would be any diŠerence between the enantiomers of cytosporone E (1) with regard to their antimicrobial activity. It is well established that the enantiomers of a bioregulator usually diŠer in their biological activities. 2, 3) We therefore undertook the syntheses of the racemate and enantiomers of cytosporone E [3-heptyl-4,5,6-trihydroxyphthalide (1)]. This paper describes the synthesis and biological evaluation of (±)-1, (R)-1 and (S )-1 which revealed their antimicrobial activities to be weak and almost the same.
Results and Discussion
Our synthesis of (±)-cytosporone E (1) is summarized in Scheme 1. In analogy with our previous synthesis of bioactive and naturally occurring phthalides, 4, 5) the Snieckus's ortho lithiation methodology 6, 7) was employed as the key step. Accordingly, commercially available 3,4,5-trimethoxybenzoyl chloride (2) was treated with diethylamine to give N, N-diethylamide 3. Lithiation of 3 with sec-butyllithium in the presence of N, N, N?, N?-tetramethylethylenediamine (TMEDA) was followed by the addition of octanal. The resulting crude mixture was saponiˆed with potassium hydroxide and then acidiˆed with dilute hydrochloric Scheme 2. Synthesis of ( R)-and ( S )-Cytosporone E (1).
Reagemts: (a) BnBr, K 2 CO 3 , DMF (96z 2585 Synthesis of Cytosporone E acid to give lactone (±)-4. Treatment of (±)-4 with boron tribromide aŠorded (±)-1, mp 162-1659 C, whose 1 H-and 13 C-NMR data were in good agreement with those reported for cytosporone E.
1) The overall yield of (±)-1 was 53z based on 2 (3 steps).
To synthesize the enantiomers of 1, weˆrst expected that our methods for the synthesis of (R)-and (S )-3-butyl-7-hydroxyphthalide would work perfectly: 5) (i) Miyaura-Suzuki coupling (Scheme 2, 7ª8), 8) (ii) Sharpless asymmetric dihydroxylation (8ª9) 9) and (iii) Barton radical deoxygenation. 10) Our expectation concerning the high enantioselectivity of the asymmetric dihydroxylation turned out to be too optimistic, and weˆnally had to use the less sophisticated method of the enantiomeric separation of 12 by preparative HPLC.
Considering the ease of its later removal, the benzyl group was selected as the protective group for the phenolic hydroxy groups of 1, and commercially available methyl 3,4,5-trihydroxybenzoate (5) was benzylated to give known 6.
11) Bromination of 6 with N-bromosuccinimide (NBS) aŠorded 7, which was subjected to Miyaura-Suzuki coupling with ( E )-1-octeneboronic acid 12) in the presence of tetrakis(triphenylphosphine)palladium and potassium carbonate to give oleˆn 8. Asymmetric dihydroxylation of 8 with AD-mix-b } 9) proceeded sluggishly to furnish enantiomerically impure (3R,1?R )-9 (45z e.e. as determined by an HPLC analysis on Daicel Chiralcel } OG) in a 54z yield after a week at 49 C. This unfavorable result was in contrast to our previous observation that asymmetric dihydroxylation of methyl ( E )-2-benzyloxy-6-(1?-pentenyl)benzoate gave the desired product of À99z e.e. The neighboring benzyloxy group in 8 must have interfered and caused deterioration in the enantioselectivity of the reaction.
Although resulting enantiomerically impure (3R,1?R )-9 was an oil, there was a possibility that one of the intermediates or evenˆnal product (S )-1 could be su‹ciently crystalline to enable us its puriˆ-cation by recrystallization. We therefore continued the synthesis. In order to deoxygenate the hydroxy group at C-1? of enantiomerically impure (3R,1?R )-9, it was converted to thiocarbonyl derivative (3R,1?R )-10. Barton deoxygenation 10) of (3R,1?R )-10 gave tribenzylated (S )-cytosporone E (11) which was debenzylated with the Pearlman catalyst under hydrogen to give (S )-cytosporone E (1) with low enantiomeric purity. Unfortunately, none of these compounds was acceptably crystalline, and we had to search for other possibilities to improve the enantiomeric purity of (S )-1.
Upon examining the HPLC behavior of (S )-1, its tribenzyl derivative (S )-11 and other derivatives of (S )-1, we found that the enantiomers of tristert-butyldimethlysilyl(TBS)-protected derivative 12 could be separated by preparative HPLC on Chiralcel } OD to give pure (S )-12 (98.4z e.e.). Deprotection of the TBS groups of (S )-12 under conventional conditions with tetra(n-butyl)ammonium ‰uoride, however, caused partial racemization of (S )-1. Fortunately, treatment of (S )-12 with dilute ethanoic hydrochloric acid at room temperature caused no appreciable racemization to give (S )-1, [a]D 24 -90.7 (c 1.00, acetone), in a 40z yield. The deprotection conditions were so mild that starting With all three of the desired samples (±)-1, (R)-1 and (S )-1 in hand, the antimicrobial activities of these samples were examined at Sankyo Co. by employing twelve diŠerent microorganisms, including four strains of Candida albicans, C. parapsilosis, C. glabrata, C. krusei, C. tropicalis, Cryptococcus neoformans, two strains of Aspergillus fumigatus, and Asp. ‰avas. The results are shown in Table 1 . All three samples showed the same degree of antimicrobial activity, which was far weaker than that of the practical antimicrobial agent, itraconazole } (Janssen).
In conclusion, (±)-, (R)-, and (S )-cytosporone E (1) were synthesized. Although cytosporone E has been claimed to show strong antimicrobial activity, 1) our synthetic samples were only weakly active as antimicrobial agents. The stereochemistry at C-3 of 1 had no particular eŠect on the bioactivity of 1, and no diŠerence was apparent with regard to the antimicrobial activity of the enantiomers of 1. In this particular case, therefore, bioactivity did not depend on the absolute conˆguration of the bioactive molecule.
Experimental
Melting point (mp) data were measured with a Yanaco MP-S3 instrument. IR spectra were measured with a Jasco FT W IR-410 spectrometer, and 1 H-NMR spectra were recorded at 500 MHz with a Jeol JNM-LA500 spectrometer. The peaks for TMS (at d ＝0.00) and acetone-d5 (at d＝2.04) were used for the internal standards. 13 C-NMR data were recorded at 126 MHz with a Jeol JNM-LA500 spectrometer. The peaks for CDCl3 (at d＝77.0) and acetone-d6 [at d＝ 29.8 (CD 3 )] were used for the internal standards. Optical rotation was measured with a Jasco P-1010 polarimeter, and EI-MS data were recorded with a Jeol JMS-AX505HA spectrometer. Column chromatography was carried out with Merck Kieselgel 60 Art 1.07734, and TLC analyses were performed with Merck 60F-254 silica gel plates.
N, N-Diethyl-3,4,5-trimethoxybenzamide (3). Under an argon atmosphere, a solution of 3,4,5-trimethoxybenzoyl chloride (2.31 g, 10.0 mmol) in THF (20 ml) was stirred and cooled with an ice-water bath, treated with diethylamine (4.14 ml, 40.0 mmol), and then further stirred for 30 min at room temperature. This mixture was concentrated in vacuo, and the residue was diluted with EtOAc. The solution was successively washed with water and brine, and dried with MgSO4, the solvent being removed in vacuo to give a colorless solid. The solid was recrystallized from hexane-EtOAc to give 3 (2.54 g, 95z), mp 48.0-49.09 C. IR n max (KBr) cm Under an argon atmosphere, a ‰ask was charged with THF (50 ml) and cooled to -789 C. TMEDA (990 ml, 7.00 mmol) followed by sec-butyllithium in cyclohexane-hexane (1.0 M, 7.00 ml, 7.00 mmol) were then added. A solution of 3 (1.34 g, 5.01 mmol) in THF (5 ml) was next added dropwise to the ‰ask. This solution was stirred for 1 h, before octanal (760 ml, 7.70 mmol) was added to the solution at -789 C, and the cooling bath was removed after 5 min. The solution was stirred for 3 h, and water was added. This mixture was concentrated in vacuo, and the residue was diluted with EtOAc. The solution was successively washed with water and brine, dried with MgSO4, and concentrated under reduced pressure. A solution of KOH (3.92 g, 70 mmol) in methanol (20 ml) and water (2 ml) was added to the residue, and the mixture was stirred for 16 h. The reaction mixture was washed with hexane. The aqueous layer was acidiˆed with 4 M HCl aq., and extracted with EtOAc. The organic layer was successively washed with water and brine, dried with MgSO4, and the solvent was removed in vacuo. The residue was chromatographed on silica gel (40 g, eluted with hexaneEtOAc) to give (±)-4 (1.15 g, 71z) as a colorless oil. IR nmax (ˆlm) cm (1 H, s, 7-H Methyl 2-Bromo-3,4,5-tribenzyloxybenzoate (7). A solution of N-bromosuccinimide (196 mg, 1.10 mmol) in DMF (4.0 ml) was added dropwise to a solution of 6 (455 mg, 1.00 mmol) in DMF (1.0 ml), and the mixture was stirred for 16 h at room temperature. The mixture was diluted with water, and extracted with EtOAc. The organic layer was successively washed with water and brine, dried with MgSO 4 , and concentrated in vacuo to give crude 7 as a brown solid. This crude product was recrystallized from hexane-EtOAc to give 7 as needles (513 mg, 96z), mp 92.0-93.09 C. IR nmax (KBr) cm ( E )-Methyl 2-(1-Octenyl)-3,4,5-tribenzyloxybenzoate (8) . To a stirred solution of 7 (24.0 g, 45.0 mmol) in benzene (300 ml) and ethanol (50 ml) were added ( E )-1-octeneboronic acid (9.36 g, 60.0 mmol), Pd(PPh3)4 (1.04 g, 0.900 mmol), and K2CO3 (37.3 g, 270 mmol). The mixture was re‰uxed for 14 h under an Ar atmosphere. The mixture was then diluted with EtOAc and successively washed with 1 M NaOH aq., water and brine. The organic layer was dried with MgSO4, and the solvent was removed in vacuo. The residue was chromatographed on silica gel (100 g, eluted with hexane-EtOAc) to give 8 (18.6 g, 71z) as a colorless oil and starting material 7 (4.57 g, 19z). . A solution of AD-mix-a } (29.4 g) and MeSO2NH2 (2.00 g, 21.0 mmol) in tertBuOH (150 ml) and water (150 ml) was stirred for 1 h at 09 C. Alkene 8 (3.95 g, 7.00 mmol) was added to the mixture which was then stirred for 7 d at 49 C, before Na2SO3･7H2O (40 g, 160 mmol) was added, the mixtureˆnally being stirred for 1 h at room temperature. This mixture was diluted with EtOAc and successively washed with water and brine, before being dried with MgSO4. The solvent was removed in vacuo. The resulting residue was chromatographed on silica gel (150 g, eluted with hexane-EtOAc) to give crude (3S,1?S)-9 (15.6 g, 39z) and starting material 8 (2.35 g, 59z 
